Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Aug;84(2):418–426. doi: 10.1172/JCI114182

Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.

A T Hirsch 1, V J Dzau 1, J A Majzoub 1, M A Creager 1
PMCID: PMC548899  PMID: 2527249

Abstract

Arginine vasopressin (AVP) is a potent vasopressor and antidiuretic neurohormone. However, when administered intravenously to humans, AVP causes forearm vasodilation. This effect has been attributed to sympathetic withdrawal, secondary to AVP-induced sensitization of baroreceptors. The possibility that AVP also causes forearm vasodilation directly has not been examined. Accordingly, the direct effect of AVP was determined by studying the forearm blood flow (FBF) response to intraarterial (IA) AVP infusion (0.01-1.0 ng/kg per min). Infusion of IA AVP increased FBF (96%) in the infused arm, but not the control arm, in a dose-dependent manner. The role of specific AVP V1 receptors in mediating this FBF response was determined before and after pretreatment with a V1 antagonist (AVP-A). AVP-A alone had no effect on FBF, but coadministration of AVP and AVP-A potentiated the vasodilatory response (223%). IA infusion of the V2 agonist, 1-desamino[8-D-arginine] vasopressin, caused a dose-dependent increase in FBF. These findings suggest that AVP causes direct, dose-dependent vasodilation in the human forearm that may be mediated by V2 vasopressinergic receptors. In contrast, AVP infusion caused digital vasoconstriction that was blocked by AVP-A, whereas dDAVP did not affect digital blood flow. Thus, AVP induces regionally selective vascular effects, with concurrent forearm vasodilation and digital vasoconstriction.

Full text

PDF
418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud F. M., Aylward P. E., Floras J. S., Gupta B. N. Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals. J Physiol. 1986 Aug;377:251–265. doi: 10.1113/jphysiol.1986.sp016185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc. 1977 May;36(6):1853–1860. [PubMed] [Google Scholar]
  3. Altura B. M. Selective microvascular constrictor actions of some neurohypophyseal peptides. Eur J Pharmacol. 1973 Oct;24(1):49–60. doi: 10.1016/0014-2999(73)90113-1. [DOI] [PubMed] [Google Scholar]
  4. Andrews C. E., Jr, Brenner B. M. Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat. Circ Res. 1981 Feb;48(2):254–258. doi: 10.1161/01.res.48.2.254. [DOI] [PubMed] [Google Scholar]
  5. Aylward P. E., Floras J. S., Leimbach W. N., Jr, Abboud F. M. Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation. 1986 Jun;73(6):1145–1154. doi: 10.1161/01.cir.73.6.1145. [DOI] [PubMed] [Google Scholar]
  6. BARTELSTONE H. J., NASMYTH P. A. VASOPRESSIN POTENTIATION OF CATECHOLAMINE ACTIONS IN DOG, RAT, CAT, AND RAT AORTIC STRIP. Am J Physiol. 1965 Apr;208:754–762. doi: 10.1152/ajplegacy.1965.208.4.754. [DOI] [PubMed] [Google Scholar]
  7. Bichet D. G., Razi M., Lonergan M., Arthus M. F., Papukna V., Kortas C., Barjon J. N. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988 Apr 7;318(14):881–887. doi: 10.1056/NEJM198804073181403. [DOI] [PubMed] [Google Scholar]
  8. Bunag R. D., Page I. H., McCubbin J. W. Inhibition of renin release by vasopressin and angiotensin. Cardiovasc Res. 1967 Jan;1(1):67–73. doi: 10.1093/cvr/1.1.67. [DOI] [PubMed] [Google Scholar]
  9. Bussien J. P., Waeber B., Nussberger J., Schaller M. D., Gavras H., Hofbauer K., Brunner H. R. Does vasopressin sustain blood pressure of normally hydrated healthy volunteers? Am J Physiol. 1984 Jan;246(1 Pt 2):H143–H147. doi: 10.1152/ajpheart.1984.246.1.H143. [DOI] [PubMed] [Google Scholar]
  10. Corliss R. J., McKenna D. H., Sialer S., O'Brien G. S., Rowe G. G. Systemic and coronary hemodynamic effects of vasopressin. Am J Med Sci. 1968 Nov;256(5):293–299. doi: 10.1097/00000441-196811000-00003. [DOI] [PubMed] [Google Scholar]
  11. Cowley A. W., Jr, Merrill D., Osborn J., Barber B. J. Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res. 1984 Feb;54(2):163–172. doi: 10.1161/01.res.54.2.163. [DOI] [PubMed] [Google Scholar]
  12. Cowley A. W., Jr, Switzer S. J., Guinn M. M. Evidence and quantification of the vasopressin arterial pressure control system in the dog. Circ Res. 1980 Jan;46(1):58–67. doi: 10.1161/01.res.46.1.58. [DOI] [PubMed] [Google Scholar]
  13. Davies R., Forsling M. L., Slater J. D. The interrelationship between the release of renin and vasopressin as defined by orthostasis and propranolol. J Clin Invest. 1977 Dec;60(6):1438–1441. doi: 10.1172/JCI108905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Derkx F. H., Man in 't Veld A. J., Jones R., Reid J. L., Schalekamp M. A. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? J Hypertens Suppl. 1983 Dec;1(2):58–61. [PubMed] [Google Scholar]
  15. Ebert T. J., Cowley A. W., Jr, Skelton M. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man. J Clin Invest. 1986 Apr;77(4):1136–1142. doi: 10.1172/JCI112413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Erwald R., Wiechel K. L. Effect of vasopressin on central and splanchnic hemodynamics in awake man. Acta Chir Scand. 1978;144(6):347–358. [PubMed] [Google Scholar]
  17. Floras J. S., Aylward P. E., Abboud F. M., Mark A. L. Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. Hypertension. 1987 Oct;10(4):409–416. doi: 10.1161/01.hyp.10.4.409. [DOI] [PubMed] [Google Scholar]
  18. Floras J. S., Aylward P. E., Gupta B. N., Mark A. L., Abboud F. M. Modulation of cardiovascular reflexes by arginine vasopressin. Can J Physiol Pharmacol. 1987 Aug;65(8):1717–1723. doi: 10.1139/y87-270. [DOI] [PubMed] [Google Scholar]
  19. Goldsmith S. R., Francis G. S., Cowley A. W., Jr, Levine T. B., Cohn J. N. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983 Jun;1(6):1385–1390. doi: 10.1016/s0735-1097(83)80040-0. [DOI] [PubMed] [Google Scholar]
  20. Guo G. B., Schmid P. G., Abboud F. M. Sites at which vasopressin facilitates baroreflex inhibition of lumbar sympathetic nerve activity. Am J Physiol. 1986 Sep;251(3 Pt 2):H644–H655. doi: 10.1152/ajpheart.1986.251.3.H644. [DOI] [PubMed] [Google Scholar]
  21. Hofbauer K. G., Studer W., Mah S. C., Michel J. B., Wood J. M., Stalder R. The significance of vasopressin as a pressor agent. J Cardiovasc Pharmacol. 1984;6 (Suppl 2):S429–S438. doi: 10.1097/00005344-198406002-00018. [DOI] [PubMed] [Google Scholar]
  22. Johnston C. I., Newman M., Woods R. Role of vasopressin in cardiovascular homeostasis and hypertension. Clin Sci (Lond) 1981 Dec;61 (Suppl 7):129s–139s. doi: 10.1042/cs061129s. [DOI] [PubMed] [Google Scholar]
  23. KITCHIN A. H. The effect of pitressin on hand and forearm blood flow. Clin Sci. 1957 Nov;16(4):639–644. [PubMed] [Google Scholar]
  24. Katusic Z. S., Shepherd J. T., Vanhoutte P. M. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res. 1984 Nov;55(5):575–579. doi: 10.1161/01.res.55.5.575. [DOI] [PubMed] [Google Scholar]
  25. Khokhär A. M., Slater J. D., Forsling M. L., Payne N. N. Effect of vasopressin on plasma volume and renin release in man. Clin Sci Mol Med. 1976 May;50(5):415–424. doi: 10.1042/cs0500415. [DOI] [PubMed] [Google Scholar]
  26. Landgraf R., Häcker R., Buhl H. Plasma vasopressin and oxytocin in response to exercise and during a day-night cycle in man. Endokrinologie. 1982 Jun;79(2):281–291. [PubMed] [Google Scholar]
  27. Laycock J. F., Penn W., Shirley D. G., Walter S. J. The role of vasopressin in blood pressure regulation immediately following acute haemorrhage in the rat. J Physiol. 1979 Nov;296:267–275. doi: 10.1113/jphysiol.1979.sp013004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liard J. F. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ Res. 1986 May;58(5):631–640. doi: 10.1161/01.res.58.5.631. [DOI] [PubMed] [Google Scholar]
  29. Liard J. F. Does vasopressin-induced vasoconstriction persist during prolonged infusion in dogs? Am J Physiol. 1987 Apr;252(4 Pt 2):R668–R673. doi: 10.1152/ajpregu.1987.252.4.R668. [DOI] [PubMed] [Google Scholar]
  30. Liard J. F., Dériaz O., Schelling P., Thibonnier M. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. Am J Physiol. 1982 Nov;243(5):H663–H669. doi: 10.1152/ajpheart.1982.243.5.H663. [DOI] [PubMed] [Google Scholar]
  31. Liard J. F. Effects of intra-arterial arginine-vasopressin infusions on peripheral blood flows in conscious dogs. Clin Sci (Lond) 1986 Dec;71(6):713–721. doi: 10.1042/cs0710713. [DOI] [PubMed] [Google Scholar]
  32. Liard J. F., Spadone J. C. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):713–719. doi: 10.1097/00005344-198407000-00026. [DOI] [PubMed] [Google Scholar]
  33. Majzoub J. A., Carrazana E. J., Shulman J. S., Baker K. J., Emanuel R. L. Defective regulation of vasopressin gene expression in Brattleboro rats. Am J Physiol. 1987 May;252(5 Pt 1):E637–E642. doi: 10.1152/ajpendo.1987.252.5.E637. [DOI] [PubMed] [Google Scholar]
  34. Malayan S. A., Ramsay D. J., Keil L. C., Reid I. A. Effects of increases in plasma vasopressin concentration on plasma renin activity, blood pressure, heart rate, and plasma corticosteroid concentration in conscious dogs. Endocrinology. 1980 Dec;107(6):1899–1904. doi: 10.1210/endo-107-6-1899. [DOI] [PubMed] [Google Scholar]
  35. Manning M., Balaspiri L., Judd J., Acosta M., Sawyer W. H. Probing the molecular basis of antidiuretic specificity and duration of action with synthetic peptides. FEBS Lett. 1974 Aug 25;44(2):229–232. doi: 10.1016/0014-5793(74)80731-3. [DOI] [PubMed] [Google Scholar]
  36. Manning M., Sawyer W. H. Antagonists of vasopressor and antidiuretic responses to arginine vasopressin. Ann Intern Med. 1982 Apr;96(4):520–522. doi: 10.7326/0003-4819-96-4-520. [DOI] [PubMed] [Google Scholar]
  37. Melin B., Eclache J. P., Geelen G., Annat G., Allevard A. M., Jarsaillon E., Zebidi A., Legros J. J., Gharib C. Plasma AVP, neurophysin, renin activity, and aldosterone during submaximal exercise performed until exhaustion in trained and untrained men. Eur J Appl Physiol Occup Physiol. 1980;44(2):141–151. doi: 10.1007/BF00421092. [DOI] [PubMed] [Google Scholar]
  38. Montani J. P., Liard J. F., Schoun J., Möhring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res. 1980 Sep;47(3):346–355. doi: 10.1161/01.res.47.3.346. [DOI] [PubMed] [Google Scholar]
  39. Moses A. M., Steciak E. Urinary and metabolic clearances of arginine vasopressin in normal subjects. Am J Physiol. 1986 Aug;251(2 Pt 2):R365–R370. doi: 10.1152/ajpregu.1986.251.2.R365. [DOI] [PubMed] [Google Scholar]
  40. Richardson D. W., Robinson A. G. Desmopressin. Ann Intern Med. 1985 Aug;103(2):228–239. doi: 10.7326/0003-4819-103-2-228. [DOI] [PubMed] [Google Scholar]
  41. Rowe J. W., Shelton R. L., Helderman J. H., Vestal R. E., Robertson G. L. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979 Dec;16(6):729–735. doi: 10.1038/ki.1979.189. [DOI] [PubMed] [Google Scholar]
  42. Schmid P. G., Abboud F. M., Wendling M. G., Ramberg E. S., Mark A. L., Heistad D. D., Eckstein J. W. Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am J Physiol. 1974 Nov;227(5):998–1004. doi: 10.1152/ajplegacy.1974.227.5.998. [DOI] [PubMed] [Google Scholar]
  43. Schwartz J., Keil L. C., Maselli J., Reid I. A. Role of vasopressin in blood pressure regulation during adrenal insufficiency. Endocrinology. 1983 Jan;112(1):234–238. doi: 10.1210/endo-112-1-234. [DOI] [PubMed] [Google Scholar]
  44. Schwartz J., Liard J. F., Ott C., Cowley A. W., Jr Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am J Physiol. 1985 Nov;249(5 Pt 2):H1001–H1008. doi: 10.1152/ajpheart.1985.249.5.H1001. [DOI] [PubMed] [Google Scholar]
  45. Swartz S. L., Williams G. H., Hollenberg N. K., Levine L., Dluhy R. G., Moore T. J. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest. 1980 Jun;65(6):1257–1264. doi: 10.1172/JCI109788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sørensen P. S., Hammer M. Vasopressin in plasma and ventricular cerebrospinal fluid during dehydration, postural changes, and nausea. Am J Physiol. 1985 Jan;248(1 Pt 2):R78–R83. doi: 10.1152/ajpregu.1985.248.1.R78. [DOI] [PubMed] [Google Scholar]
  47. Undesser K. P., Hasser E. M., Haywood J. R., Johnson A. K., Bishop V. S. Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res. 1985 Mar;56(3):410–417. doi: 10.1161/01.res.56.3.410. [DOI] [PubMed] [Google Scholar]
  48. Vilhardt H., Lundin S., Falch J. Plasma kinetics of DDAVP in man. Acta Pharmacol Toxicol (Copenh) 1986 May;58(5):379–381. doi: 10.1111/j.1600-0773.1986.tb00125.x. [DOI] [PubMed] [Google Scholar]
  49. Walker B. R. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am J Physiol. 1986 Jul;251(1 Pt 2):H34–H39. doi: 10.1152/ajpheart.1986.251.1.H34. [DOI] [PubMed] [Google Scholar]
  50. Walker L. A., Whorton A. R., Smigel M., France R., Frölich J. C. Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol. 1978 Sep;235(3):F180–F185. doi: 10.1152/ajprenal.1978.235.3.F180. [DOI] [PubMed] [Google Scholar]
  51. Wang B. C., Sundet W. D., Hakumäki M. O., Goetz K. L. Vasopressin and renin responses to hemorrhage in conscious, cardiac-denervated dogs. Am J Physiol. 1983 Sep;245(3):H399–H405. doi: 10.1152/ajpheart.1983.245.3.H399. [DOI] [PubMed] [Google Scholar]
  52. Zusman R. M., Keiser H. R. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest. 1977 Jul;60(1):215–223. doi: 10.1172/JCI108758. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES